These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 9212326)
1. Amylin and the gastrointestinal tract. Macdonald IA Diabet Med; 1997 Jun; 14 Suppl 2():S24-8. PubMed ID: 9212326 [TBL] [Abstract][Full Text] [Related]
2. Role of amylin in nutrient intake - animal studies. Young A Diabet Med; 1997 Jun; 14 Suppl 2():S14-8. PubMed ID: 9212324 [TBL] [Abstract][Full Text] [Related]
3. Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus. Vella A; Lee JS; Camilleri M; Szarka LA; Burton DD; Zinsmeister AR; Rizza RA; Klein PD Neurogastroenterol Motil; 2002 Apr; 14(2):123-31. PubMed ID: 11975712 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of gastric emptying. Young A Adv Pharmacol; 2005; 52():99-121. PubMed ID: 16492543 [TBL] [Abstract][Full Text] [Related]
5. Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM. Kong MF; King P; Macdonald IA; Stubbs TA; Perkins AC; Blackshaw PE; Moyses C; Tattersall RB Diabetologia; 1997 Jan; 40(1):82-8. PubMed ID: 9028722 [TBL] [Abstract][Full Text] [Related]
6. The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM. Kong MF; Stubbs TA; King P; Macdonald IA; Lambourne JE; Blackshaw PE; Perkins AC; Tattersall RB Diabetologia; 1998 May; 41(5):577-83. PubMed ID: 9628276 [TBL] [Abstract][Full Text] [Related]
7. Effects of amylin and the amylin agonist pramlintide on glucose metabolism. Schmitz O; Nyholm B; Orskov L; Gravholt C; Møller N Diabet Med; 1997 Jun; 14 Suppl 2():S19-23. PubMed ID: 9212325 [TBL] [Abstract][Full Text] [Related]
8. Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Young AA; Gedulin B; Vine W; Percy A; Rink TJ Diabetologia; 1995 Jun; 38(6):642-8. PubMed ID: 7672483 [TBL] [Abstract][Full Text] [Related]
9. [Role of amylin in glucose homeostasis and its perspective use in diabetes management]. Otto-Buczkowska E; Mazur-Dworzecka U; Dworzecki T Przegl Lek; 2008; 65(3):135-9. PubMed ID: 18624122 [TBL] [Abstract][Full Text] [Related]
10. Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. Samsom M; Szarka LA; Camilleri M; Vella A; Zinsmeister AR; Rizza RA Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G946-51. PubMed ID: 10859225 [TBL] [Abstract][Full Text] [Related]
11. Pramlintide: A new tool in diabetes management. Want LL; Ratner RE Curr Diab Rep; 2006 Nov; 6(5):344-9. PubMed ID: 17076994 [TBL] [Abstract][Full Text] [Related]
12. Pramlintide for the treatment of diabetes mellitus. Kleppinger EL; Vivian EM Ann Pharmacother; 2003; 37(7-8):1082-9. PubMed ID: 12841822 [TBL] [Abstract][Full Text] [Related]
18. Clinical implications of amylin and amylin deficiency. Kruger DF; Gatcomb PM; Owen SK Diabetes Educ; 1999; 25(3):389-97; quiz 398. PubMed ID: 10531859 [TBL] [Abstract][Full Text] [Related]
19. Amylin reduces plasma glucagon concentration in cats. Furrer D; Kaufmann K; Reusch CE; Lutz TA Vet J; 2010 May; 184(2):236-40. PubMed ID: 19299171 [TBL] [Abstract][Full Text] [Related]
20. Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control. Weyer C; Maggs DG; Young AA; Kolterman OG Curr Pharm Des; 2001 Sep; 7(14):1353-73. PubMed ID: 11472273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]